Your browser doesn't support javascript.
loading
Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry.
Cobo Marcos, Marta; de la Espriella, Rafael; Gayán Ordás, Jara; Zegrí, Isabel; Pomares, Antonia; Llácer, Pau; Fort, Aleix; Rodríguez Chavarri, Adriana; Méndez, Ana; Blázquez, Zorba; Caravaca Pérez, Pedro; Rubio Gracia, Jorge; Recio-Mayoral, Alejandro; García Pinilla, Jose Manuel; Soler, Maria Jose; Garrido González, Ramón; Górriz, Jose Luis; González Rico, Miguel; Castro, Almudena; Núñez, Julio.
Afiliação
  • Cobo Marcos M; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda (IDIPHISA), Madrid, Spain.
  • de la Espriella R; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
  • Gayán Ordás J; Department of Cardiology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain.
  • Zegrí I; Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.
  • Pomares A; Department of Cardiology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Llácer P; Department of Cardiology, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Fort A; Internal Medicine Department, Hospital Universitario Ramón Y Cajal, IRYCIS, Madrid, Spain. Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain.
  • Rodríguez Chavarri A; Department of Cardiology, Hospital Universitari Dr. Josep Trueta., Girona, Spain.
  • Méndez A; Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.
  • Blázquez Z; Department of Cardiology, Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Caravaca Pérez P; Department of Cardiology, Hospital Universtiario Gregorio Marañón, Madrid, Spain.
  • Rubio Gracia J; Department of Cardiology, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Recio-Mayoral A; Department of Internal Medicine, Hospital Universitario Lozano Blesa, University of Zaragoza, Saragossa, Spain.
  • García Pinilla JM; Department of Cardiology, Hospital Universitario Virgen Macarena, Seville, Spain.
  • Soler MJ; Department of Cardiology, Hospital Universitario Virgen de La Victoria, Málaga, Spain.
  • Garrido González R; Department of Nephrology, Hospital Universitario Vall d´Hebron, Barcelona, Spain.
  • Górriz JL; Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda (IDIPHISA), Madrid, Spain.
  • González Rico M; Department of Nephrology, Hospital Clínico Universitario Valencia (INCLIVA), University of Valencia, Valencia, Spain.
  • Castro A; Department of Nephrology, Hospital Clínico Universitario Valencia (INCLIVA), University of Valencia, Valencia, Spain.
  • Núñez J; Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain.
Curr Heart Fail Rep ; 20(3): 157-167, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37222949
ABSTRACT
PURPOSE OF THE WORK Although sex-specific differences in heart failure (HF) or kidney disease (KD) have been analyzed separately, the predominant cardiorenal phenotype by sex has not been described. This study aims to explore the sex-related differences in cardiorenal syndrome (CRS) in a contemporary cohort of outpatients with HF.

FINDINGS:

An analysis of the Cardiorenal Spanish registry (CARDIOREN) was performed. CARDIOREN Registry is a prospective multicenter observational registry including 1107 chronic ambulatory HF patients (37% females) from 13 Spanish HF clinics. Estimated Glomerular Filtration Rate (eGFR) < 60 ml/min/1.73 m2 was present in 59.1% of the overall HF population, being this prevalence higher in the female population (63.2% vs. 56.6%, p = 0.032, median age 81 years old, IQR74-86). Among those with kidney dysfunction, women displayed higher odds of showing HF with preserved ejection fraction (HFpEF) (odds ratio [OR] = 4.07; confidence interval [CI] 95% 2.65-6.25, p < 0.001), prior valvular heart disease (OR = 1.76; CI 95%1.13-2.75, p = 0.014), anemia (OR 2.02; CI 95%1.30-3.14, p = 0.002), more advanced kidney disease (OR for CKD stage 3 1.81; CI 95%1.04-3.13, p = 0.034; OR for CKD stage 4 2.49, CI 95%1.31-4.70, p = 0.004) and clinical features of congestion (OR1.51; CI 95% 1.02-2.25, p = 0.039). On the contrary, males with cardiorenal disease showed higher odds of presenting HF with reduced ejection fraction (HFrEF) (OR3.13; CI 95% 1.90-5.16, p < 0.005), ischemic cardiomyopathy (OR2.17; CI 95% 1.31-3.61, p = 0.003), hypertension (OR = 2.11; CI 95%1.18-3.78, p = 0.009), atrial fibrillation (OR1.71; CI 95% 1.06-2.75, p = 0.025), and hyperkalemia (OR2.43, CI 95% 1.31-4.50, p = 0.005). In this contemporary registry of chronic ambulatory HF patients, we observed sex-related differences in patients with combined heart and kidney disease. The emerging cardiorenal phenotype characterized by advanced CKD, congestion, and HFpEF was predominantly observed in women, whereas HFrEF, ischemic etiology, hypertension, hyperkalemia, and atrial fibrillation were more frequently observed in men.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Insuficiência Renal Crônica / Síndrome Cardiorrenal / Insuficiência Cardíaca / Hiperpotassemia / Hipertensão Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Insuficiência Renal Crônica / Síndrome Cardiorrenal / Insuficiência Cardíaca / Hiperpotassemia / Hipertensão Idioma: En Ano de publicação: 2023 Tipo de documento: Article